Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy
Fabio MazzolaniPrivate Practice, Milan, ItalyBackground: The purpose of this open-label study was to investigate the effect of a curcumin-phospholipid (lecithin, Meriva®) formulation (Norflo® tablet) on visual acuity and retinal thickness in patients with acute or chronic cen...
Enregistré dans:
Auteur principal: | Mazzolani F |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/58d75bbf3e204cec8b374bbd77705fcf |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study
par: Mazzolani F, et autres
Publié: (2013) -
Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy
par: Chin EK, et autres
Publié: (2015) -
Low-dose aspirin as treatment for central serous chorioretinopathy
par: Antonio Caccavale, et autres
Publié: (2010) -
Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
par: Karim SP, et autres
Publié: (2013) -
Transpupillary thermotherapy for atypical central serous chorioretinopathy
par: Kawamura R, et autres
Publié: (2012)